Vmedvil2 Posted January 16, 2020 Report Posted January 16, 2020 (edited) It seems that the technique of Multi-valent Recombinant Pseudotyping work for making a vaccine vector against Ebola Virus when introduced into primate and human patients, read more at https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(19)30614-0/fulltext Edited January 16, 2020 by VictorMedvil Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.